WNV Treatment Licensed
Novartis Animal Vaccines announced Aug. 19 the conditional licensing and availability of the only antibody product approved by the USDA to help control disease caused by West Nile virus (WNV) in equids. This product helps an exposed animal by increasing the antibody level in the circulatory system, which enhances an animal’s ability to neutralize virus already in the blood.
For a product



